Playing Piano to Improve Hand Function Early After Stroke
Launched by MCGILL UNIVERSITY · Sep 27, 2024
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring whether playing the piano can help improve hand function in people recovering from a stroke. Specifically, the study is looking at how feasible it is to include piano training in the rehabilitation process and whether participants find these sessions enjoyable and helpful. The researchers want to compare the effects of piano training to standard therapy on skills like hand movements, coordination, and even mood.
To be eligible for the trial, participants should be 18 years or older and must have had their first stroke within the last 24 weeks. They should also be able to follow simple instructions and have some ability to move their arms and fingers. Those with significant cognitive issues or prior piano experience will not be included. If chosen for the study, participants in the piano group will attend two 45-minute sessions each week for six weeks, along with additional home practice. The other group will receive standard occupational therapy. This research could offer new insights into improving recovery after a stroke through creative activities like music.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Have normal/corrected visual and auditory acuity
- • Present a first-ever supratentorial unilateral stroke (1-24 weeks post-stroke)
- • Present some capacity of dissociation of arm and finger movements, as reflected by scores of 3 to 6 on the arm and hand components of the Chedoke McMaster Stroke Assessment
- • Have the capacity to follow simple instructions
- • Have no professional piano experience (only for the piano group)
- Exclusion Criteria:
- • Presence of visual field defect, hemineglect as well as dementia or moderate-to-severe cognitive deficits (score less than 18 on the Montreal Cognitive Assessment).
About Mcgill University
McGill University, a prestigious research institution located in Montreal, Canada, is committed to advancing medical science through innovative clinical trials. Renowned for its rigorous academic standards and collaborative approach, McGill fosters a dynamic environment that integrates cutting-edge research with clinical practice. With a focus on improving patient outcomes, the university's clinical trials span a wide range of therapeutic areas, leveraging the expertise of its diverse faculty and state-of-the-art facilities. McGill University is dedicated to ethical research practices and the dissemination of knowledge, ensuring that findings contribute meaningfully to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Laval, Quebec, Canada
Patients applied
Trial Officials
Anouk Lamontagne, PhD
Principal Investigator
McGill University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported